chr19-8586451-A-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_030957.4(ADAMTS10):​c.2423T>G​(p.Leu808Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00539 in 1,613,800 control chromosomes in the GnomAD database, including 367 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.027 ( 205 hom., cov: 32)
Exomes 𝑓: 0.0031 ( 162 hom. )

Consequence

ADAMTS10
NM_030957.4 missense

Scores

2
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.31

Publications

7 publications found
Variant links:
Genes affected
ADAMTS10 (HGNC:13201): (ADAM metallopeptidase with thrombospondin type 1 motif 10) This gene belongs to the ADAMTS (a disintegrin and metalloproteinase domain with thrombospondin type-1 motifs) family of zinc-dependent proteases. ADAMTS proteases are complex secreted enzymes containing a prometalloprotease domain of the reprolysin type attached to an ancillary domain with a highly conserved structure that includes at least one thrombospondin type 1 repeat. They have been demonstrated to have important roles in connective tissue organization, coagulation, inflammation, arthritis, angiogenesis and cell migration. The product of this gene plays a major role in growth and in skin, lens, and heart development. It is also a candidate gene for autosomal recessive Weill-Marchesani syndrome. [provided by RefSeq, Jul 2008]
ADAMTS10 Gene-Disease associations (from GenCC):
  • Weill-Marchesani syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Weill-Marchesani syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003006488).
BP6
Variant 19-8586451-A-C is Benign according to our data. Variant chr19-8586451-A-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 330585.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0911 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADAMTS10NM_030957.4 linkc.2423T>G p.Leu808Arg missense_variant Exon 21 of 26 ENST00000597188.6 NP_112219.3 Q9H324A0A0A0MQW6Q6ZN14Q59FE5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADAMTS10ENST00000597188.6 linkc.2423T>G p.Leu808Arg missense_variant Exon 21 of 26 5 NM_030957.4 ENSP00000471851.1 A0A0A0MQW6

Frequencies

GnomAD3 genomes
AF:
0.0273
AC:
4152
AN:
152176
Hom.:
204
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0936
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0121
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000632
Gnomad OTH
AF:
0.0182
GnomAD2 exomes
AF:
0.00744
AC:
1858
AN:
249630
AF XY:
0.00583
show subpopulations
Gnomad AFR exome
AF:
0.0941
Gnomad AMR exome
AF:
0.00597
Gnomad ASJ exome
AF:
0.00120
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000930
Gnomad NFE exome
AF:
0.000905
Gnomad OTH exome
AF:
0.00542
GnomAD4 exome
AF:
0.00311
AC:
4540
AN:
1461506
Hom.:
162
Cov.:
32
AF XY:
0.00285
AC XY:
2075
AN XY:
727078
show subpopulations
African (AFR)
AF:
0.0943
AC:
3158
AN:
33480
American (AMR)
AF:
0.00635
AC:
284
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.00165
AC:
43
AN:
26126
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.000232
AC:
20
AN:
86256
European-Finnish (FIN)
AF:
0.0000753
AC:
4
AN:
53094
Middle Eastern (MID)
AF:
0.0168
AC:
97
AN:
5768
European-Non Finnish (NFE)
AF:
0.000450
AC:
500
AN:
1111992
Other (OTH)
AF:
0.00717
AC:
433
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
314
628
942
1256
1570
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
116
232
348
464
580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0273
AC:
4160
AN:
152294
Hom.:
205
Cov.:
32
AF XY:
0.0267
AC XY:
1987
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.0935
AC:
3886
AN:
41546
American (AMR)
AF:
0.0121
AC:
185
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4830
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10622
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000632
AC:
43
AN:
68014
Other (OTH)
AF:
0.0180
AC:
38
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
207
414
622
829
1036
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0102
Hom.:
181
Bravo
AF:
0.0317
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.0883
AC:
389
ESP6500EA
AF:
0.00105
AC:
9
ExAC
AF:
0.00881
AC:
1069
Asia WGS
AF:
0.00520
AC:
18
AN:
3478
EpiCase
AF:
0.000600
EpiControl
AF:
0.00160

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 16, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Weill-Marchesani syndrome Benign:1
Jan 15, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
20
DANN
Uncertain
1.0
Eigen
Benign
-0.0052
Eigen_PC
Benign
0.038
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.80
T;T;.
MetaRNN
Benign
0.0030
T;T;T
MetaSVM
Benign
-1.1
T
PhyloP100
2.3
PrimateAI
Benign
0.43
T
PROVEAN
Benign
1.2
.;N;.
REVEL
Benign
0.080
Sift
Benign
0.087
.;T;.
Sift4G
Benign
0.061
T;T;T
Vest4
0.72
MVP
0.32
MPC
1.6
ClinPred
0.020
T
GERP RS
3.5
gMVP
0.82
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10420313; hg19: chr19-8651335; API